Truist Financial raises Boston Scientific (NYSE:BSX) price target from $60 to $61

By / / Boston Scientific, Truist Financial

Truist Financial analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $60 to $61.

Scroll to Top